| Susan E Clift, | |
|
4315 Diplomacy Dr, Attn: Sherry Reedy, Anchorage, AK 99508-5926 | |
| (907) 729-3971 | |
| (907) 729-1542 |
| Full Name | Susan E Clift |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 4315 Diplomacy Dr, Anchorage, Alaska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437106051 | NPI | - | NPPES |
| MD0857 | Medicaid | AK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 4230 (Alaska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Susan E Clift, 4315 Diplomacy Dr, Attn: Sherry Reedy, Anchorage, AK 99508-5926 Ph: (907) 729-3971 | Susan E Clift, 4315 Diplomacy Dr, Attn: Sherry Reedy, Anchorage, AK 99508-5926 Ph: (907) 729-3971 |
News Archive
Mr. Raymond Moody - a 4th year doctoral student in Health Psychology and Clinical Science training program at the CUNY Graduate Center and a graduate student researcher at Hunter College's Center for HIV/AIDS Educational Studies and Training has been awarded a two year grant totaling $155,972 from the National Institute on Drug Abuse to support his dissertation research.
New research which has identified 20 sections of genetic code linked to height may also lead to new treatments for arthritis and cancer.
Malaria caused by a parasite that is borne in female mosquitoes and that spreads in humans through mosquito bites is a major public health problem and it kills more than a million people world wide each year. With the rise of resistance of many of the strains of the malaria parasite to most of the anti-malarial drugs the problem is escalating at an alarming pace.
Active Biotech and Ipsen today announced that recruitment to the global, pivotal, randomized, double-blind, placebo-controlled phase III study of tasquinimod in patients with metastatic castrate-resistant prostate cancer (CRPC) has reached an inclusion of 600 patients, half of the planned accrual.
Inviragen today reported top-line results of a placebo-controlled, randomized Phase 1 trial of INV21, the Company's highly purified virus particle vaccine against Hand, Foot and Mouth Disease (HFMD) caused by enterovirus 71.
› Verified 7 days ago
Candace L Clawson, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 4315 Diplomacy Dr, Anchorage, AK 99508 Phone: 907-729-1624 Fax: 907-729-1634 | |
Dr. William Murray Buttner, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1201 E 36th Ave, Anchorage, AK 99508 Phone: 907-562-9229 Fax: 907-561-4806 | |
Robert L Mcalister, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1201 E 36th Ave, Anchorage, AK 99508 Phone: 907-562-2992 | |
Shane W Cummings, M D Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1310 E Dimond Blvd, Suite 1, Anchorage, AK 99515 Phone: 907-344-2400 Fax: 907-344-2404 | |
Jeremy D Wood, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 910 Compassion Cir, Anchorage, AK 99504 Phone: 907-212-9200 Fax: 907-212-9283 | |
Kelton Hillard Oliver, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 12302 Woodward Dr, Anchorage, AK 99516 Phone: 907-580-0002 | |
Ryan T. Mcwilliams, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4320 Diplomacy Dr, Suite 1191, Anchorage, AK 99508 Phone: 907-729-6321 |